Nexeon Medsystems Inc
OTC:NXNN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Osirium Technologies PLC
LSE:OSI
|
UK |
We don't have any information about NXNN's insider trading.
Nexeon Medsystems Inc
Glance View
Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. The company is headquartered in West Palm Beach, Florida. The company went IPO on 2017-08-01. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology. In addition, the Company is developing and commercializing NNS, an implantable neurostimulation and recording platform. The Company’s wholly-owned subsidiaries include Nexeon Medsystems Europe, SARL (Nexeon Europe), Nexeon Medsystems Puerto Rico Operating Company Corporation (NXPROC) and Pulsus Medical LLC.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
